HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Heart Congress 2027

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Understanding personalized & precision cardiology (PPC) focuses on customizing medical interventions based on an individual’s unique genetic profile, biomarkers, targets and personal health data. Unlike conventional cardiology, which relies on generalized treatment guid [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibiting [....] » Read More

Bijoy Krishna Banik, Speaker at Heart Conferences
Oral Presentation (In-Person)
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India

Introduction: Doxorubicin (DOX) is a broadly used anthracycline anticancer drug, but its therapeutic application is limited by cumulative, dose?dependent cardiotoxicity that may culminate in heart failure. Oxidative stress, mitochondrial impairment and activation of apoptotic pat [....] » Read More

Will be updated soon......
Agustin Joison, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduction: Globally, ischemic heart disease has become one of the leading causes of disability-adjusted life years (DALYs), ranking first among adults over the age of 50. Residual risk can be classified into three main domains, residual lipid risk: persists despite LDL-C contr [....] » Read More

Watsapp